Ozanimod, Ozanimod, Ozanimod
IM047-001
Phase 3 small_molecule active
Quick answer
Ozanimod, Ozanimod, Ozanimod for Moderately to Severely Active Ulcerative Colitis is a Phase 3 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Moderately to Severely Active Ulcerative Colitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active